Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.003 Å; disorder in solvent or counterion; R factor = 0.045; wR factor = 0.132; data-toparameter ratio = 14.2.
In the asymmetric unit of the title compound, C 16 H 15 ClN 4 OÁ-0.75CH 3 OH, there are two independent quinazolin-4(3H)-one molecules and one and a half methanol molecules. One of the methanol molecules is disordered over two positions with equal occupancies. The dihedral angles between the quinazoline ring system and the chlorobenzene ring in the two quinazolin-4(3H)-one molecules are essentially the same, at 39.83 (1) and 39.84 (1) . Intramolecular N-HÁ Á ÁN and O-HÁ Á ÁO, and intermolecular N-HÁ Á ÁO and N-HÁ Á ÁN hydrogen bonds are observed. In addition, -stacking interactions, with centroid-to-centroid distances of 3.654 (1), 3.766 (1) and 3.767 (1) Å , and weak C-HÁ Á Á interactions, are observed.
Related literature
For the biological activity of quinazoline-4(3H)-one derivatives, see: Bartroli et al. (1998) ; Kung et al. (1999) ; Malamas & Millen (1991) ; Mannschreck et al. (1984) ; Matsuno et al. (2002) ; Palmer et al. (1997) ; Pandeya et al. (1999) ; Shiba et al. (1997) ; Tsou et al. (2001) . For the synthesis of the title compound, see: Hu et al. (2006) ; Yang et al. (2008) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). 
; (iv) x À 1; y; z. Cg1, Cg2 and Cg4 are the centroids of the N2/C7/N3/C8-C10, C1-C6 and N6/ C23/N7/C24-C26 rings, respectively. Data collection: SMART (Bruker, 2000) ; cell refinement: SAINT (Bruker, 2000) ; data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: SHELXTL (Sheldrick, 2008) ; software used to prepare material for publication: SHELXTL.
3-(2-Aminoethyl)-2-(4-chloroanilino)quinazolin-4(3H)-one methanol 0.75-solvate X.-H. Yang, X.-B. Chen and S.-X. Zhou Comment Quinazoline-4(3H)-one derivatives have broad biological properties. Some of these activities include antimicrobial (Pandeya et al., 1999; Shiba et al., 1997) , antidiabetic (Malamas & Millen, 1991) , anticonvulsant (Mannschreck et al., 1984) , antibacterial (Kung et al., 1999) , antifungal (Bartroli et al., 1998) , protein tyrosine kinase inhibitors (Palmer et al., 1997) , EGFR inhibitors (Tsou et al., 2001) and PDGFR phosphorylation inhibitors (Matsuno et al., 2002) . We have recently focused on the synthesis of heterocyclic compounds using an aza-Wittig reaction. We have reported the synthesis of the title compound (Yang et al., 2008) . We present here the crystal structure of the title compound, (I) (Fig. 1) , which can be used as a precursor for obtaining bioactive molecules.
In the crystal structure, there are two quinazolin-4(3H)-one molecules in the asymmetric unit. The quinazoline heterocycle and the adjacent chlorobenzene ring are not planar, but inclined at 39.83 (1)°. Significant intramolecular N-H···N and O-H···O and intermolecular N-H···O and N-H···N hydrogen bonds contribute strongly to the stability of the molecular configuration ( Fig. 2 and Table 1 ). The crystal structure (Fig. 2) is stabilized by weak intermolecular C-H···π hydrogen bonds (Table 1) and by π-π stacking interactions with centroid-centroid separations of 3.654 (1), 3.767 (1) 
The title compound was prepared according to the literature method (Hu et al., 2006; Yang et al., 2008) . Single crystals suitable for X-ray diffraction were obtained from a methanol-dichloromethane (1:1 v/v) solution at room temperature.
Refinement
One of the methanol solvent molecules was found to be disordered over two positions. Their final occupancies were set to be 0.5:0.5. H atoms bonded to C were placed at calculated positions, with C-H distances of 0.97 and 0.93 Å for H atoms bonded to sp 3 and sp 2 C atoms, respectively. They were refined using a riding model, with U iso (H) = 1.2U eq (C) or 1.5U eq (methyl C). H atoms bonded to N and O atoms were found in a difference map and then refined with distance restraints of N-H = 0.86 (2) Å and O-H = 0.82 (2) Å, and with U iso (H) = 1.2U eq (N) and 1.5U eq (O).
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Figures Fig. 1 . View of the molecular structure of (I), showing the atom labelling scheme and with displacement ellipsoids drawn at the 50% probability level. 
